| Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease JL Tillerson, WM Caudle, ME Reveron, GW Miller Neuroscience 119 (3), 899-911, 2003 | 533 | 2003 |
| Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration WM Caudle, JR Richardson, MZ Wang, TN Taylor, TS Guillot, ... Journal of Neuroscience 27 (30), 8138-8148, 2007 | 442 | 2007 |
| Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity TN Taylor, WM Caudle, KR Shepherd, AR Noorian, CR Jackson, ... Journal of Neuroscience 29 (25), 8103-8113, 2009 | 304 | 2009 |
| Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine JL Tillerson, WM Caudle, ME Reverón, GW Miller Experimental neurology 178 (1), 80-90, 2002 | 239 | 2002 |
| Forced nonuse in unilateral parkinsonian rats exacerbates injury JL Tillerson, AD Cohen, WM Caudle, MJ Zigmond, T Schallert, GW Miller Journal of Neuroscience 22 (15), 6790-6799, 2002 | 219 | 2002 |
| Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease JR Richardson, WM Caudle, M Wang, ED Dean, KD Pennell, GW Miller, ... The FASEB Journal 20 (10), 1695-1697, 2006 | 217 | 2006 |
| Industrial toxicants and Parkinson's disease WM Caudle, TS Guillot, CR Lazo, GW Miller Neurotoxicology 33 (2), 178-188, 2012 | 183 | 2012 |
| Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder JR Richardson, MM Taylor, SL Shalat, TS Guillot III, WM Caudle, ... The FASEB Journal 29 (5), 1960, 2015 | 163 | 2015 |
| Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor JL Tillerson, WM Caudle, JM Parent, C Gong, T Schallert, GW Miller Behavioural brain research 172 (1), 97-105, 2006 | 157 | 2006 |
| Biomarker discovery in neurodegenerative diseases: a proteomic approach M Shi, WM Caudle, J Zhang Neurobiology of disease 35 (2), 157-164, 2009 | 147 | 2009 |
| Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling MJ Decker, GE Hue, WM Caudle, GW Miller, GL Keating, DB Rye Neuroscience 117 (2), 417-425, 2003 | 147 | 2003 |
| Altered vesicular dopamine storage in Parkinson's disease: a premature demise WM Caudle, RE Colebrooke, PC Emson, GW Miller Trends in neurosciences 31 (6), 303-308, 2008 | 144 | 2008 |
| Glutamate, excitotoxicity, and programmed cell death in Parkinson disease WM Caudle, J Zhang Experimental neurology 220 (2), 230-233, 2009 | 142 | 2009 |
| Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease X Hu, D Zhang, H Pang, WM Caudle, Y Li, H Gao, Y Liu, L Qian, B Wilson, ... The Journal of Immunology 181 (10), 7194-7204, 2008 | 141 | 2008 |
| Pyrethroid pesticide-induced alterations in dopamine transporter function MA Elwan, JR Richardson, TS Guillot, WM Caudle, GW Miller Toxicology and applied pharmacology 211 (3), 188-197, 2006 | 141 | 2006 |
| Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) JR Richardson, WM Caudle, TS Guillot, JL Watson, E Nakamaru-Ogiso, ... Toxicological Sciences 95 (1), 196-204, 2007 | 139 | 2007 |
| Polychlorinated biphenyl–induced reduction of dopamine transporter expression as a precursor to Parkinson's disease–associated dopamine toxicity WM Caudle, JR Richardson, KC Delea, TS Guillot, M Wang, KD Pennell, ... Toxicological Sciences 92 (2), 490-499, 2006 | 128 | 2006 |
| Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease AR Dunn, KA Stout, M Ozawa, KM Lohr, CA Hoffman, AI Bernstein, Y Li, ... Proceedings of the National Academy of Sciences 114 (11), E2253-E2262, 2017 | 123 | 2017 |
| Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter AB Manning-Boğ, WM Caudle, XA Perez, SH Reaney, R Paletzki, MZ Isla, ... Neurobiology of disease 27 (2), 141-150, 2007 | 115 | 2007 |
| VMAT2‐deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson′ s disease TN Taylor, WM Caudle, GW Miller Parkinson’s disease 2011 (1), 124165, 2011 | 113 | 2011 |
